AGC
BDSI

Alden Global Capital’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Alden Global Capital’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-133,500
Closed -$639K – 36
2015
Q4 		$639K Buy
+133,500
New +$757K 0.32% 24

Other funds holding BDSI

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
FPC
Falcon Point Capital San Francisco, California $11.9M AUM 55.76% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Alden Global Capital's BDSI Position: Q1 2016 in Review

Alden Global Capital sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2016, closing a stake of 133,500 shares — an estimated $639K sold.

Alden Global Capital first reported a position in BDSI in Q4 2015 and held it in 1 quarter. The position peaked at $639K in Q4 2015. 105 funds tracked by Wall St. Rank hold BDSI as of Q1 2016.

  • Alden Global Capital reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2016 after selling out during the quarter.
  • Alden Global Capital sold 133,500 BioDelivery Sciences International, Inc. shares in Q1 2016, an estimated $639K.
  • Alden Global Capital first reported a position in BioDelivery Sciences International, Inc. in Q4 2015 and held it in 1 quarter.
  • Alden Global Capital's BioDelivery Sciences International, Inc. position peaked at $639K in Q4 2015.
  • 105 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2016.

Based on Alden Global Capital's 13F filing for Q1 2016, filed 13 May 2016.